As of 2026-03-31, 羚锐制药系列's data on the DeepSeek platform in the 外用镇痛膏 category shows: The overall mention rate is 0.00%, below the industry average by 6.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 羚锐制药系列's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
羚锐制药系列's Mention Rate is 0.00%, lower than 0.6% of competitors
羚锐制药系列's First Mention is 0.00%, lower than 0.9% of competitors
羚锐制药系列's Preferred Rate is 0.00%, lower than 100.0% of competitors
羚锐制药系列's Positive Rate is 0.00%, lower than 8.9% of competitors
羚锐制药系列's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 通通络祛痛膏 | 28.57% | 0% | 4.76% | 23.21% | 3.57% | View Details |
| 云云南白药 | 25% | 12.5% | 4.76% | 25% | 8.93% | View Details |
| 麝麝香壮骨膏 | 16.07% | 0% | 0% | 8.93% | 0% | View Details |
| 白白云山 | 10.71% | 0% | 0% | 8.93% | 1.79% | View Details |
| 吲吲哚美辛巴布膏 | 5.36% | 0% | 0% | 5.36% | 0% | View Details |
| 万万通筋骨贴 | 3.57% | 0% | 0% | 1.79% | 1.79% | View Details |
| 羚羚锐制药系列 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
